• 1
    Manolagas SC 2000 Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115137.
  • 2
    Parfitt AM 1990 Bone-forming cells in clinical conditions. HallBK (ed.) Bone. Volume 1. The Osteoblast and Osteocyte. Telford Press and CRC Press, Boca Raton, FL, USA, 351429.
  • 3
    Boyce BF, Xing L, Jilka RL, Bellido T, Weinstein RS, Parfitt AM, Manolagas SC 2002 Apoptosis in bone cells. BilezikianJP, RaiszLG, RodanG (eds.) Principles of Bone Biology, 2nd ed. Academic Press, San Diego, CA, USA, 151168.
  • 4
    Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC 1998 Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines. J Bone Miner Res 13: 793802.
  • 5
    Kroemer G, Galluzzi L, Brenner C 2007 Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99163.
  • 6
    Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJD, Cheng EHY 2006 Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 13481358.
  • 7
    Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci PG 2005 Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221233.
  • 8
    Kumar S 2006 Caspase function in programmed cell death. Cell Death Differ 14: 3243.
  • 9
    Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R 1990 Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11: 847853.
  • 10
    Pompeiano M, Hvala M, Chun J 1998 Onset of apoptotic DNA fragmentation can precede cell elimination by days in the small intestinal villus. Cell Death Differ 5: 702709.
  • 11
    Kerr JF, Wyllie AH, Currie AR 1972 Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239257.
  • 12
    Wijsman JH, Jonker RR, Keijzer R, van de Velde CJ, Cornelisse CJ, van Dierendonck JH 1993 A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 41: 712.
  • 13
    Silvestrini G, Mocetti P, Ballanti P, Di Grezia R, Bonucci E 1998 In vivo incidence of apoptosis evaluated with the TdT FragEL DNA fragmentation detection kit in cartilage and bone cells of the rat tibia. Tissue Cell 30: 627633.
  • 14
    Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: Potential mechanisms of their deleterious effects on bone. J Clin Invest 102: 274282.
  • 15
    Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL 2003 Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts: A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278: 5025950272.
  • 16
    Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T 1999 Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104: 13631374.
  • 17
    Tidball JG, Albrecht DE 1998 Regulation of apoptosis by cellular interactions with the extracellular matrix. LockshinRA, ZakeriZ, TillyJL (eds.) When Cells Die, vol 15. Wiley-Liss, New York, NY, USA, 411426.
  • 18
    Parfitt AM, Han ZH, Palnitkar S, Rao DS, Shih MS, Nelson D 1997 Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone. J Bone Miner Res 12: 18641873.
  • 19
    Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM 1997 Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: Implications for mechanisms of bone loss. J Bone Miner Res 12: 498508.
  • 20
    Parfitt AM, Villanueva AR, Foldes J, Rao DS 1995 Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res 10: 466473.
  • 21
    Weinstein S, Michael P, Robert M, Maria G, Gerald C, Muchmore B 2003 Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women. Osteoporos Int 14: 814822.
  • 22
    Martin RB, Yeh OC, Fyhrie DP 2007 On sampling bones for microcracks. Bone 40: 11591165.
  • 23
    Sheng MHC, Lau K-HW, Mohan S, Baylink DJ, Wergedal JE 2006 High osteoblastic activity in C3H/HeJ mice compared to C57BL/6J mice is associated with low apoptosis in C3H/HeJ osteoblasts. Calcif Tissue Int 78: 293301.
  • 24
    Landry P, Sadasivan K, Marino A, Albright J 1997 Apoptosis is coordinately regulated with osteoblast formation during bone healing. Tissue Cell 29: 413419.
  • 25
    Li G, White G, Connolly C, Marsh D 2002 Cell proliferation and apoptosis during fracture healing. J Bone Miner Res 17: 791799.
  • 26
    Olmedo ML, Landry PS, Sadasivan KK, Albright JA, Marino AA 2000 Programmed cell death in post-traumatic bone callus. Cell Mol Biol (Noisy -le-grand) 46: 8997.
  • 27
    Komatsu DE, Bosch-Marce M, Semenza GL, Hadjiargyrou M 2007 Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1α deficiency. J Bone Miner Res 22: 366374.
  • 28
    Palumbo C, Ferretti M, De Pol A 2003 Apoptosis during intramembranous ossification. J Anat 203: 589598.
  • 29
    Rice DP, Kim HJ, Thesleff I 1999 Apoptosis in murine calvarial bone and suture development. Eur J Oral Sci 107: 265275.
  • 30
    Li G, Dickson GR, Marsh DR, Simpson H 2003 Rapid new bone tissue remodeling during distraction osteogenesis is associated with apoptosis. J Orthop Res 21: 2835.
  • 31
    Cruickshank J, Grossman DI, Peng RK, Famula TR, Oberbauer AM 2005 Spatial distribution of growth hormone receptor, insulin-like growth factor-I receptor and apoptotic chondrocytes during growth plate development. J Endocrinol 184: 543553.
  • 32
    Zou H, Niswander L 1996 Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272: 738741.
  • 33
    Hay E, Lemonnier J, Fromigue O, Marie PJ 2001 Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276: 2902829036.
  • 34
    Hay E, Lemonnier J, Fromigue O, Guenou H, Marie PJ 2004 Bone morphogenetic protein receptor IB signaling mediates apoptosis independently of differentiation in osteoblastic cells. J Biol Chem 279: 16501658.
  • 35
    Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S 2005 Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280: 4134241351.
  • 36
    Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F 2003 High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960974.
  • 37
    Bodine PV, Billiard J, Moran RA, Ponce-de-Leon H, McLarney S, Mangine A, Scrimo MJ, Bhat RA, Stauffer B, Green J, Stein GS, Lian JB, Komm BS 2005 The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J Cell Biochem 96: 12121230.
  • 38
    Bodine PVN, Zhao W, Kharode YP, Bex FJ, Lambert AJ, Goad MB, Gaur T, Stein GS, Lian JB, Komm BS 2004 The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 18: 12221237.
  • 39
    Grey A, Chen Q, Xu X, Callon K, Cornish J 2003 Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells. Endocrinology 144: 48864893.
  • 40
    Hurley MM, Tetradis S, Huang YF, Hock J, Kream BE, Raisz LG, Sabbieti MG 1999 Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Miner Res 14: 776783.
  • 41
    Bellido T, O'Brien CA, Roberson PK, Manolagas SC 1998 Transcriptional activation of the p21WAF1,CIP1,SDI1 gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem 273: 2113721144.
  • 42
    Borton AJ, Frederick JP, Datto MB, Wang XF, Weinstein RS 2001 The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res 16: 17541764.
  • 43
    Tsuboi M, Kawakami A, Nakashima T, Matsuoka N, Urayama S, Kawabe Y, Fujiyama K, Kiriyama T, Aoyagi T, Maeda K, Eguchi K 1999 Tumor necrosis factor-α and interleukin-1β increase the Fas-mediated apoptosis of human osteoblasts. J Lab Clin Med 134: 222231.
  • 44
    Verderio EAM, Telci D, Okoye A, Melino G, Griffin M 2003 A novel RGD-independent cell adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J Biol Chem 278: 4260442614.
  • 45
    Globus RK, Doty SB, Lull JC, Holmuhamedov E, Humphries MJ, Damsky CH 1998 Fibronectin is a survival factor for differentiated osteoblasts. J Cell Sci 111: 13851393.
  • 46
    Zhao W, Byrne MH, Wang Y, Krane SM 2000 Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J Clin Invest 106: 941949.
  • 47
    Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell 104: 719730.
  • 48
    Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC 2003 Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111: 16511664.
  • 49
    Vertino AM, Bula CM, Chen JR, Almeida M, Han L, Bellido T, Kousteni S, Norman AW, Manolagas SC 2005 Nongenotropic, anti-apoptotic signaling of 1α,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes: Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J Biol Chem 280: 1413014137.
  • 50
    Tomkinson A, Gevers EF, Wit JM, Reeve J, Noble BS 1998 The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res 13: 12431250.
  • 51
    Tomkinson A, Reeve J, Shaw RW, Noble BS 1997 The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 31283135.
  • 52
    Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298: 843846.
  • 53
    Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M 1997 Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186: 489495.
  • 54
    Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 2: 11321136.
  • 55
    Gohel A, McCarthy MB, Gronowicz G 1999 Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 140: 53395347.
  • 56
    Weinstein RS, Nicholas RW, Manolagas SC 2000 Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85: 29072912.
  • 57
    O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS 2004 Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145: 18351841.
  • 58
    Tuckermann J, Schilling AF, Priemel M, Stride B, Kirilov M, Wintermantel T, Tronche F, Amling M, Scheutz G 2005 Glucocorticoid induced osteoporosis requires the glucocorticoid receptor in osteoblasts and does not depend on DNA binding of the receptor. J Bone Miner Res 20: S27.
  • 59
    Plotkin LI, Manolagas SC, Bellido T 2007 Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival: Evidence for inside-out signaling to anoikis. J Biol Chem (in press).
  • 60
    Canalis E, Delany AM 2002 Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 966: 7381.
  • 61
    Wang FS, Lin CL, Chen YJ, Wang CJ, Yang KD, Huang YT, Sun YC, Huang HC 2005 Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology 146: 24152423.
  • 62
    Jia D, O'Brien CA, Stewart SA, Manolagas SC, Weinstein RS 2006 Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147: 55925599.
  • 63
    Lindsay R, Cosman F, Zhou H, Bostrom MP, Shen VW, Cruz JD, Nieves JW, Dempster DW 2006 A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: Early actions of teriparatide. J Bone Miner Res 21: 366373.
  • 64
    Ma YL, Zeng Q, Donley DW, Ste-Marie LG, Gallagher JC, Dalsky GP, Marcus R, Eriksen EF 2006 Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res 21: 855864.
  • 65
    Jilka RL 2007 Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40: 14341446.
  • 66
    Miao D, Li J, Xue Y, Su H, Karaplis AC, Goltzman D 2004 Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice. Endocrinology 145: 35543562.
  • 67
    Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC 2005 Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1–34. J Clin Invest 115: 24022411.
  • 68
    Chen HL, Demiralp B, Schneider A, Koh AJ, Silve C, Wang CY, McCauley LK 2002 Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem 277: 1937419381.
  • 69
    Machwate M, Harada S, Leu CT, Seedor G, Labelle M, Gallant M, Hutchins S, Lachance N, Sawyer N, Slipetz D, Metters KM, Rodan SB, Young R, Rodan GA 2001 Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol Pharmacol 60: 3641.
  • 70
    Lindsay R, Zhou H, Cosman F, Nieves J, Dempster DW, Hodsman AB 2007 Effects of a one-month treatment with parathyroid hormone (1–34) on bone formation on cancellous, endocortical and periosteal surfaces of the human ilium. J Bone Miner Res 22: 495502.
  • 71
    Almeida M, Han L, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O'Brien CA, Bellido Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC 2007 Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem (in press).
  • 72
    Parfitt A, Weinstein R, Bellido T, Jilka R, O'Brien C, Goellner J, Kousteni S, Stewart S, Roberson R, Manolagas SC 2005 Age-related loss of bone strength in the spine and hindlimb of mice independently of BMD. J Bone Miner Res 20: S214.
  • 73
    Arden KC 2007 FoxOs in tumor suppression and stem cell maintenance. Cell 128: 235237.
  • 74
    Essers MA, Vries-Smits LM, Barker N, Polderman PE, Burgering BM, Korswagen HC 2005 Functional interaction between β-catenin and FOXO in oxidative stress signaling. Science 308: 11811184.
  • 75
    Kenyon C 2005 The plasticity of aging: Insights from long-lived mutants. Cell 120: 449460.
  • 76
    Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME 2004 Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 20112015.
  • 77
    Burgering BM, Kops GJ 2002 Cell cycle and death control: Long live Forkheads. Trends Biochem Sci 27: 352360.
  • 78
    Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, Lam EW, Burgering BM 2002 Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 22: 20252036.
  • 79
    Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM 2002 Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316321.
  • 80
    Medema RH, Kops GJ, Bos JL, Burgering BM 2000 AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782787.
  • 81
    Nemoto S, Finkel T 2002 Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 24502452.
  • 82
    Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR 2002 A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2: 8191.
  • 83
    Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ Jr, DiStefano PS, Chiang LW, Greenberg ME 2002 DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296: 530534.
  • 84
    Moon RT, Bowerman B, Boutros M, Perrimon N 2002 The promise and perils of Wnt signaling through β-catenin. Science 296: 16441646.
  • 85
    Staal FJ, Clevers H 2000 Tcf/Lef transcription factors during T-cell development: Unique and overlapping functions. Hematol J 1: 36.
  • 86
    Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C, Armstrong SA, Passegue E, DePinho RA, Gilliland DG 2007 FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128: 325339.
  • 87
    Almeida M, Han L, Martin-Millan M, O'Brien CA, Manolagas SC 2007 Oxidative stress antagonizes WNT signaling in osteoblast precursors by diverting B-catenin from TCF- to FOXO-mediated transcription. J Biol Chem (in press).
  • 88
    Aguirre JI, Plotkin LI, Stewart SA, Weinstein RS, Parfitt AM, Manolagas SC, Bellido T 2006 Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res 21: 605615.
  • 89
    Noble BS, Peet N, Stevens HY, Brabbs A, Mosley JR, Reilly GC, Reeve J, Skerry TM, Lanyon LE 2003 Mechanical loading: Biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol 284: C934C943.
  • 90
    Verborgt O, Gibson GJ, Schaffler MB 2000 Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 15: 6067.
  • 91
    Gohel AR, Hand AR, Gronowicz GA 1995 Immunogold localization of β1-integrin in bone: Effect of glucocorticoids and insulin-like growth factor I on integrins and osteocyte formation. J Histochem Cytochem 43: 10851096.
  • 92
    Aarden EM, Nijweide PJ, Plas A, Alblas MJ, Mackie EJ, Horton MA, Helfrich MH 1996 Adhesive properties of isolated chick osteocytes in vitro. Bone 18: 305313.
  • 93
    You LD, Weinbaum S, Cowin SC, Schaffler MB 2004 Ultrastructure of the osteocyte process and its pericellular matrix. Anat Rec 278A: 505513.
  • 94
    Bakker A, Klein-Nulend J, Burger E 2004 Shear stress inhibits while disuse promotes osteocyte apoptosis. Biochem Biophys Res Commun 320: 11631168.
  • 95
    Plotkin LI, Mathov I, Aguirre JI, Parfitt AM, Manolagas SC, Bellido T 2005 Mechanical stimulation prevents osteocyte apoptosis: Requirement of integrins, Src kinases, and ERKs. Am J Physiol 289: C633C643.
  • 96
    Manolagas SC 2006 Perspective: Choreography from the tomb: An emerging role of dying osteocytes in the purposeful, and perhaps not so purposeful, targeting of bone remodeling. BoneKey-Osteovision 3: 514; 3/1/5 doi: 10.1138/20060193.
  • 97
    Felson DT, Anderson JJ 1987 Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet 1: 902906.
  • 98
    Weinstein RS, Jia D, Chambers TM, Hogan EA, Berryhill SB, Shelton R, Stewart SA, Jilka RL, Manolagas SC 2006 Aging C57BL/6 mice exhibit increased glucocorticoid production in association with decreased bone formation, wall width and canalicular circulation: Novel mechanistic insights into the involutional loss of bone mass and strength. J Bone Miner Res 21: S62.
  • 99
    Negoescu A, Lorimier P, Labat-Moleur F, Drouet C, Robert C, Guillermet C, Brambilla C, Brambilla E 1996 In situ apoptotic cell labeling by the TUNEL method: Improvement and evaluation on cell preparations. J Histochem Cytochem 44: 959968.
  • 100
    Labat-Moleur F, Guillermet C, Lorimier P, Robert C, Lantuejoul S, Brambilla E, Negoescu A 1998 TUNEL apoptotic cell detection in tissue sections: Critical evaluation and improvement. J Histochem Cytochem 46: 327334.